[Antiphospholipid syndrome in valvular heart diseases, ischemic heart disease and vascular thrombosis].
The antiphospholipid syndrome (APS) leads to venous and arterial thrombosis, cardiac diseases, neurological, gastroenterological and dermatological complications. The role of antiphospholipid antibodies in genesis of thrombi by interaction with plasma clotting factors is well known. There is no evidence of their influence on valvular heart diseases or atherogenesis. This paper presents views and opinions about APS and related cardiovascular complications.
Grabowski
M
M
I Klinika Wad Serca Instytutu Kardiologii, Warszawa.
Brzezińska
A
A
D016736:Antiphospholipid Syndrome / Q000150:complications*; D003328:Coronary Thrombosis / Q000209:etiology*; D006349:Heart Valve Diseases / Q000209:etiology*; D006801:Humans; D017202:Myocardial Ischemia / Q000209:etiology*; D020246:Venous Thrombosis / Q000209:etiology*